Genetically Engineered and Implantable Mouse Brain Tumor Models: Characterization by Immunohistochemistry and Flow
Apoorva Mirji1,2,3, Gurveer Singh1,2,3, Anzar A Mujeeb1,2,3
1Department of Neurosurgery, Michigan Medicine, University of Michigan Medical School, Ann Arbor, Michigan.
This study introduces mouse models for aggressive gliomas using the Sleeping Beauty transposase system. These models enable detailed analysis of tumor progression and the tumor microenvironment for experimental treatment evaluation.
Area of Science:
- Oncology
- Genetics
- Immunology
Background:
- Gliomas are aggressive brain tumors with limited treatment options.
- Studying glioma progression and the tumor microenvironment (TME) is crucial for developing effective therapies.
Purpose of the Study:
- To present protocols for generating and analyzing mouse glioma models.
- To establish a preclinical platform for evaluating experimental treatments and understanding tumor biology.
Main Methods:
- Utilizing the Sleeping Beauty (SB) transposase system to create de novo mouse glioma models.
- Employing luciferase and fluorescent markers for monitoring tumor growth and gene expression.
- Generating orthotopic implantable tumors and neurospheres for further study.
- Performing immunohistochemistry (IHC) and flow cytometry for TME analysis.
Main Results:
- The SB system effectively generates mouse models that mimic human gliomas.
- These models allow for tracking tumor initiation, progression, and response to therapies in immunocompetent hosts.
- Analysis of the TME and histopathological features is feasible.
Conclusions:
- The described protocols provide a robust method for preclinical glioma research.
- These mouse models offer a relevant platform for investigating glioma pathogenesis and therapeutic strategies.
More Related Videos
09:52An Orthotopic Glioblastoma Mouse Model Maintaining Brain Parenchymal Physical Constraints and Suitable for Intravital Two-photon Microscopy
Published on: April 21, 2014
11:14Creating Anatomically Accurate and Reproducible Intracranial Xenografts of Human Brain Tumors
Published on: September 24, 2014
